Lazarus Enterprises
Overview
By using deep learning and millions of patients' records, we are a no-touch screening method for cervical cancer with over 90% accuracy. We make money by selling per test and subscriptions to physicians/hospitals and selling anonymous datasets to insurance companies/research companies.